
Oncomatryx Biopharma
Developer of stroma-targeted precision drugs and diagnostics created to fight against invasive tumours. The company is aimed at discovering new mechanisms and proteins in the peritumoral stroma, the c...
Valuation
$0
Share Price
N/A
Total Raised
$78.5M
Last Round
N/A